Industry News

• Bruker and Agilent announce agreement for Bruker to acquire certain Varian products  Bruker and Agilent Technologies announced that Bruker and Agilent have entered into a definitive asset purchase agreement. Bruker will acquire certain product lines of Varian, which Agilent has committed to divest.
  Bruker Corporation March 09, 2010  
• Abbott enhances pharmaceutical pipeline with acquisition of Facet Biotech  Abbott and Facet Biotech announced a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.
  Abbott March 09, 2010  
• Vaccinating children against flu helps protect wider community  Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well.
  National Institutes of Health March 09, 2010  
• Bristol-Myers Squibb and AstraZeneca announce the commencement of the SAVOR-TIMI 53  BMS and AstraZeneca announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial (SAVOR-TIMI 53), a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA(TM)(saxagliptin).
  Bristol-Myers Squibb Company March 09, 2010  
• Monsanto to break ground on new breeding station in Mississippi  To better serve the needs of southern farmers, Monsanto plans to open a new corn breeding station in Flora, Mississippi. The $2.4 million facility further boosts the company's investment in the South and is a reflection of Monsanto's commitment to continue delivering new high-performing products.
  Monsanto Company March 09, 2010  
• Caliper Life Sciences reports fourth quarter and full year 2009 results  GAAP revenues for the quarter increased to $37.7 million, or 3%, from $36.7 million in the same period in 2008. Fourth quarter revenue growth from the Company's ongoing business operations, which excludes the effects of divested non-core operations, was 13% compared to the same period in 2008.
  Caliper Life Sciences, Inc. March 09, 2010  
• Harvard Bioscience launches its first regenerative medicine product  Harvard Bioscience announced the launch of its ORGANIZER(TM) Series Model 100 "In Breath" bioreactor. This bioreactor was used to grow the bronchus used in the clinical transplantation performed by Prof. Paolo Macchiarini of the Dept. of General Thoracic Surgery, Hospital Clinic, Barcelona, Spain.
  Harvard Bioscience, Inc. March 09, 2010  
• Sanofi-aventis and Merck to create a global leader in Animal Health  Sanofi-aventis and Merck & Co. announced that sanofi-aventis has exercised its option to combine Merial with Intervet/Schering-Plough, Merck's Animal Health business, to create a global leader in Animal Health.
  Merck & Co., Inc. March 09, 2010  
• Acetylon licenses drug tech from Harvard, Dana-Farber  Acetylon Pharmaceuticals reports it has licensed a drug discovery platform and a group of enzyme inhibitors from Harvard University and the Dana-Farber Cancer Institute.
  Mass High Tech March 08, 2010  
• ImmunoGen announces Orphan Drug Designation granted to IMGN901  ImmunoGen announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC).
  ImmunoGen, Inc. March 08, 2010  

   (next 10 articles)